HPs Ps NPs p value
Sex
Male 8 (7.5%) 16 (15%) 83 (77.6%) 0.35
Female 8 (14.5%) 8 (14.5%) 39 (70.9%)
ECOG PS 0.70
0 0 (0%) 1 (25%) 3 (75%)
1 16 (10.1%) 23 (14.6%) 119 (75.3%)
Lung metastasis 0.97
No 4 (10.8%) 5 (13.5%) 28 (77.7%)
Yes 12 (9.8%) 18 (14.8%) 92 (75.4%)
Liver metastasis 0.35
No 10 (8.4%) 16 (13.4%) 93 (78.2%)
Yes 6 (15%) 7 (17.5%) 27 (67.5%)
Pleural effusion 0.85
No 5 (8.3%) 9 (15%) 46 (76.7%)
Yes 11 (11.1%) 14 (14.1%) 74(74.7%)
Bone metastasis 0.92
No 10 (10.9%) 13 (14.1%) 69 (75%)
Yes 6 (9%) 10 (14.9%) 51 (76.1)
Number of metastatic lesions 0.45
<2 7 (7.5%) 14 (15.1%) 72 (77.4%)
≥2 9 (13.8%) 9 (13.8%) 48 (72.7%)
PD-L1 expression 0.71
1-24% 8 (11.6%) 12 (17.4%) 49 (71%)
25-49% 6 (7.5%) 10 (12.5%) 64 (80%)
>50% 2 (15.4%) 2 (15.4%) 9 (69.2%)
NLR <0.0001
≤5 1 (1.2%) 10 (11.8%) 74 (87.1%)
>5 15 (19.5%) 14 (18.2%) 48 (62.3%)
PLR 0.004
≤median 3 (3.6%) 9 (10.8%) 71 (85.5%)
>median 13 (16.5%) 15 (19%) 51 (64.6%)
Age 0.71
<65 years 9 (8.5%) 16 (15.1%) 81 (76.4%)
≥65 years 7 (12.5%) 8 (14.3%) 41 (73.2%)
Sarcopenia <0.0001
No 1 (1.3%) 11 (14.3%) 65 (84.4%)
Yes 15 (50%) 7 (23.3%) 8 (26.7%)